Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Japan and China reach deal over Fukushima water release and move closer to resolving seafood ban
Japan and China said Friday they have reached a deal toward resolving their disputes over the discharge of treated radioactive wastewater from the tsunami-hit Fukushima Daiichi nuclear power plant int
Japan and China reach deal over Fukushima water release
Japan and China said Friday they have reached a deal toward resolving their disputes over the discharge of treated radioactive wastewater from the tsunami-hit Fukushima Daiichi nuclear power plant int
China, Japan Agree Fukushima Discharge Plan, Paving Way to Restart Seafood Trade
China and Japan reached an agreement over the discharge of wastewater from the wrecked Fukushima nuclear plant, the two governments said on Friday, paving the way for a restart of seafood shipments from Japan to China.
China to ease Japanese seafood import ban gradually
China will soon begin easing an import ban on all Japanese seafood, after alleviating concerns related to monitoring treated wastewater from the Fukushima Daiichi Nuclear Power Plant, officials said Friday.
China Says It Will ‘Gradually’ Resume Imports of Japanese Seafood
China imposed a ban last year after Japan began releasing treated water from the Fukushima nuclear plant into the sea. They have agreed to expand monitoring of the water.
Japan Eyes Deal to End Chinese Ban on Seafood Imports, Media Say
China and Japan may be close to a breakthrough over Beijing’s ban on seafood imports from Japan, imposed last year in response to the release of treated radioactive water into the sea from the crippled Fukushima nuclear power plant,
Final preparations underway for China to resume Japan seafood imports, NHK says
Japan and China are making final preparations towards the resumption of imports by China of Japanese seafood and other marine products after regulatory monitoring of radioactive water was expanded, public broadcaster NHK reported on Friday.
GlobalData on MSN
20h
NHS England to offer Daiichi Sankyo’s quizartinib for AML
The UK Medicines and Healthcare products Regulatory Agency previously confirmed the asset’s safety and efficacy.
3d
on MSN
Daiichi Sankyo-Merck's cancer drug meets main goal in late-stage trial
Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal in a late-stage study in ...
2d
Daiichi Sankyo: Showing No Signs Of Slowing Down ADC Dominance
ADCs, particularly Enhertu and datopotamab deruxtecan, are showing promising results. See why I rate the stock a buy.
3d
Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study
Merck reported topline data from its HERTHENA-Lung02 phase 3 trial of patritumab deruxtecan in EGFR-mutated non-small cell ...
MM&M
12h
Daiichi Sankyo launches first DTC ad for Enhertu, representing shift toward patient-centric oncology campaigns
Daiichi Sankyo has launched a new direct-to-consumer (DTC) campaign for Enhertu — the first DTC effort for its oncology unit ...
FierceBiotech
3d
Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data
A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...
FiercePharma
17h
Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
2d
on MSN
Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial
Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...
pharmaphorum
1d
Daiichi Sankyo's Vanflyta gets NICE nod for leukaemia
NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...
FiercePharma
1d
Daiichi, AZ's first Enhertu DTC campaign kicks off during Thursday Night Football
As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...
14h
Japan and China End Dispute Over Nuclear Plant Wastewater
Japan's Prime Minister Fumio Kishida announced that the two countries have achieved a "level of mutual understanding." ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Merck
China
Japan
Food and Drug Administration
Enhertu
Feedback